Moleculin Biotech, Inc. (MBRX) (CIK 0001659617) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001437749-25-029979
- Form
- CORRESP
- Filer
- Moleculin Biotech, Inc. (MBRX) (CIK 0001659617)
- CIK
- 0001659617
- Ticker
- MBRX
- Filed
- 2025-09-29
- SIC industry
- 2834
- HQ
- Houston, TX
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1659617/000143774925029979/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer